173 related articles for article (PubMed ID: 37547501)
21. Application of Scores Assessing Histological Activity and Estimated Long-Term Risk Analysis of Hepatic Decompensation of Non-Alcoholic Fatty Liver Disease in Individuals Undergoing Bariatric Surgery.
Hatto M; Ivano VK; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
Obes Surg; 2023 May; 33(5):1580-1586. PubMed ID: 37004688
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis.
Selvaraj EA; Mózes FE; Jayaswal ANA; Zafarmand MH; Vali Y; Lee JA; Levick CK; Young LAJ; Palaniyappan N; Liu CH; Aithal GP; Romero-Gómez M; Brosnan MJ; Tuthill TA; Anstee QM; Neubauer S; Harrison SA; Bossuyt PM; Pavlides M;
J Hepatol; 2021 Oct; 75(4):770-785. PubMed ID: 33991635
[TBL] [Abstract][Full Text] [Related]
23. How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography-A Review of the Literature and Proposed Multistep Approach.
Taru MG; Neamti L; Taru V; Procopciuc LM; Procopet B; Lupsor-Platon M
Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832276
[TBL] [Abstract][Full Text] [Related]
24. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.
Harrison SA; Gawrieh S; Roberts K; Lisanti CJ; Schwope RB; Cebe KM; Paradis V; Bedossa P; Aldridge Whitehead JM; Labourdette A; Miette V; Neubauer S; Fournier C; Paredes AH; Alkhouri N
J Hepatol; 2021 Aug; 75(2):284-291. PubMed ID: 33746083
[TBL] [Abstract][Full Text] [Related]
25. Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis.
Manka P; Bechmann L; Best J; Sydor S; Claridge LC; Coombes JD; Canbay A; Moeller L; Gerken G; Wedemeyer H; Syn WK
Dig Dis Sci; 2019 Aug; 64(8):2351-2358. PubMed ID: 31155687
[TBL] [Abstract][Full Text] [Related]
26. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.
McGlinchey AJ; Govaere O; Geng D; Ratziu V; Allison M; Bousier J; Petta S; de Oliviera C; Bugianesi E; Schattenberg JM; Daly AK; Hyötyläinen T; Anstee QM; Orešič M
JHEP Rep; 2022 May; 4(5):100477. PubMed ID: 35434590
[TBL] [Abstract][Full Text] [Related]
27. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
[TBL] [Abstract][Full Text] [Related]
28. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA
Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
[TBL] [Abstract][Full Text] [Related]
29. The Predictive Role of Parathyroid Hormone for Nonalcoholic Fatty Liver Disease following Bariatric Surgery.
Jamialahmadi T; Nematy M; Abdalla M; Jangjoo A; Goshayeshi L; Kroh M; Moallem SA; Abbasifard M; Sathyapalan T; Sahebkar A
J Nutr Metab; 2022; 2022():7319742. PubMed ID: 35265372
[TBL] [Abstract][Full Text] [Related]
30. Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging.
Guzmán-Aroca F; Frutos-Bernal MD; Bas A; Luján-Mompeán JA; Reus M; Berná-Serna Jde D; Parrilla P
Eur Radiol; 2012 Nov; 22(11):2525-32. PubMed ID: 22648049
[TBL] [Abstract][Full Text] [Related]
31. The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients.
Ganjooei NA; Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Khadem-Rezaiyan M; Reiner Ž; Alidadi M; Markin AM; Sahebkar A
Front Cardiovasc Med; 2021; 8():682352. PubMed ID: 34136549
[No Abstract] [Full Text] [Related]
32. Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetes.
Bril F; Kadiyala S; Portillo Sanchez P; Sunny NE; Biernacki D; Maximos M; Kalavalapalli S; Lomonaco R; Suman A; Cusi K
J Investig Med; 2016 Jan; 64(1):63-8. PubMed ID: 26755815
[TBL] [Abstract][Full Text] [Related]
33. SHOULD ROUTINE LIVER BIOPSY BE CONSIDERED IN BARIATRIC SURGICAL PRACTICE? AN ANALYSIS OF THE LIMITATIONS OF NON-INVASIVE NAFLD MARKERS.
Concon MM; Gestic MA; Utrini MP; Chaim FDM; Chaim EA; Cazzo E
Arq Gastroenterol; 2022; 59(1):110-116. PubMed ID: 35442320
[TBL] [Abstract][Full Text] [Related]
34. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
Chakrabarty M; Jha AN; Sharma DJ
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
[TBL] [Abstract][Full Text] [Related]
35. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S
JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831
[TBL] [Abstract][Full Text] [Related]
36. PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS.
Smiderle CA; Coral GP; DE Carli LA; Mattos AA; Mattos AZ; Tovo CV
Arq Gastroenterol; 2021; 58(2):139-144. PubMed ID: 34231659
[TBL] [Abstract][Full Text] [Related]
37. Non-alcoholic fatty liver disease (NAFLD) in lean individuals - Single centre large cohort clinicopathologic and immunophenotypic study.
Rastogi A; Rath I; Varadarajan A; Ramakrishna G; Bihari C; Maiwall R
Pathol Res Pract; 2022 Oct; 238():154112. PubMed ID: 36126451
[TBL] [Abstract][Full Text] [Related]
38. Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet.
Schwenger KJP; Fischer SE; Jackson TD; Okrainec A; Allard JP
Obes Surg; 2018 Apr; 28(4):1109-1116. PubMed ID: 29098545
[TBL] [Abstract][Full Text] [Related]
39. Correlation Between Anthropometric Measurements and Non-alcoholic Fatty Liver Disease in Individuals With Obesity Undergoing Bariatric Surgery: Cross-Sectional Study.
Reis SS; Callejas GH; Marques RA; Gestic MA; Utrini MP; Chaim FDM; Ramos AC; Chaim EA; Cazzo E
Obes Surg; 2021 Aug; 31(8):3675-3685. PubMed ID: 33982243
[TBL] [Abstract][Full Text] [Related]
40. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
